• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [18583 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2021     Health Information and Quality Authority (HIQA) Economic burden of antimicrobial resistance: an analysis of additional costs associated with resistant infections
2021     European Network for Health Technology Assessment (EUnetHTA) APN01 for the treatment of COVID-19
2021     Health Information and Quality Authority (HIQA) Health technology assessment of birth cohort testing for hepatitis C
2021     European Network for Health Technology Assessment (EUnetHTA) Darunavir for the treatment of COVID-19
2021     European Network for Health Technology Assessment (EUnetHTA) Favipiravir for the treatment of COVID-19
2021     European Network for Health Technology Assessment (EUnetHTA) Sarilumab for the treatment of COVID-19
2021     European Network for Health Technology Assessment (EUnetHTA) Interferon (IFN) and Novaferon (NOVA) for the treatment of COVID-19
2021     Health Information and Quality Authority (HIQA) Identification of demand models for estimating the quantities of personal protective equipment (PPE) required for optimal patient care in the context of COVID-19
2021     European Network for Health Technology Assessment (EUnetHTA) Gimsilumab for the treatment of COVID-19
2021     European Network for Health Technology Assessment (EUnetHTA) Canakinumab for the treatment of COVID-19
2021     Health Information and Quality Authority (HIQA) Rapid antigen testing for screening or surveillance of asymptomatic individuals to limit transmission of SARS-CoV-2
2021     European Network for Health Technology Assessment (EUnetHTA) Casirivimab and imdevimab (REGN-COV2) for the treatment of COVID-19
2021     Health Information and Quality Authority (HIQA) Reduction of the minimum age for the application of mask wearing requirements and recommendations – updated advice
2021     NIHR Public Health Research (PHR) programme A cluster randomised controlled trial of an intervention to improve the mental health support and training available to secondary school teachers the WISE (Wellbeing in Secondary Education) project
2021     European Network for Health Technology Assessment (EUnetHTA) Bamlanivimab for the treatment of COVID-19
2021     NIHR Health Technology Assessment programme Reducing bias in trials from reactions to measurement: the MERIT study including developmental work and expert workshop
2021     European Network for Health Technology Assessment (EUnetHTA) Baricitinib for the treatment of COVID-19
2021     European Network for Health Technology Assessment (EUnetHTA) Molnupiravir for the treatment of COVID-19
2021     Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS) [Training programming for healthcare professionals: How to support patients with chronic diseases to self-manage their health]
2021     European Network for Health Technology Assessment (EUnetHTA) High-dose vitamin D for the treatment of COVID-19
2021     Ontario Health Stance-control knee–ankle–foot orthoses for people with knee instability: a health technology assessment
2021     Center for Drug Evaluation (CDE) [Health economic evaluation of three listed anti-cancer medications]
2021     European Network for Health Technology Assessment (EUnetHTA) Mavrilimumab for the treatment of COVID-19
2021     Austrian Institute for Health Technology Assessment (AIHTA) Stool DNA testing for colorectal cancer (CRC) screening
2021     Center for Drug Evaluation (CDE) [Review of international guidelines and comparative effectiveness of high cost antidiabetes drugs]
2021     European Network for Health Technology Assessment (EUnetHTA) Ivermectin for the treatment of COVID-19
2021     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: hospital at home, an alternative to conventional hospitalization]
2021     Center for Drug Evaluation (CDE) [Descriptive study and comparative effectiveness of listed medications for osteoporosis on new osteoporotic fracture event in osteoporosis patients by using National Health Insurance claim database]
2021     European Network for Health Technology Assessment (EUnetHTA) Aspirin for the treatment of COVID-19
2021     NIHR Health Technology Assessment programme Non-invasive imaging software to assess the functional significance of coronary stenoses: a systematic review and economic evaluation
2021     Center for Drug Evaluation (CDE) [A systematic review of the comparative efficacy and cost-effectiveness of current listed statins in Taiwan]
2021     NIHR Health Technology Assessment programme The ACUTE (Ambulance CPAP: Use, Treatment effect and Economics) feasibility study: a pilot randomised controlled trial of prehospital CPAP for acute respiratory failure
2021     Swiss Federal Office of Public Health (FOPH) Corneal collagen crosslinking for the treatment of progressive keratoconus
2021     Swiss Federal Office of Public Health (FOPH) Infliximab reference product versus biosimilar for the treatment of rheumatoid arthritis
2021     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards: needs analysis grid for families followed by Integrated Perinatal and Early Childhood Services (SIPPE)]
2021     Swiss Federal Office of Public Health (FOPH) Medical cannabis for treating various symptoms in Switzerland
2021     Center for Evidence-based Practice (CEP) Fall risk assessment in oncology patients
2021     Ontario Health Molecular testing for thyroid nodules with atypical cells of indeterminate significance
2021     Swiss Federal Office of Public Health (FOPH) Palbociclib (Ibrance®), ribociclib (Kisqali®) and abemaciclib (Verzenios®) for the treatment of hormone receptor (HR)-positive, human epidermal growth factor (HER2)-negative advanced breast cancer
2021     Center for Evidence-based Practice (CEP) Effects of masks on the health of schoolchildren
2021     NIHR Health Technology Assessment programme A non-inferiority randomised controlled trial comparing the clinical and cost-effectiveness of one session treatment (OST) with multi-session cognitive behavioural therapy (CBT) in children with specific phobias
2021     Ontario Health Nonthermal minimally invasive treatments for varicose veins
2021     Swiss Federal Office of Public Health (FOPH) Subacromial decompression as a primary/isolated intervention to treat subacromial pain
2021     Ontario Health Prostatic artery embolization for benign prostatic hyperplasia
2021     Swiss Federal Office of Public Health (FOPH) The treatment of hypercholesterolaemia and mixed/combined hyperlipidaemia with ezetimibe-containing medicines
2021     Ontario Health Skin substitutes for adults with diabetic foot ulcers and venous leg ulcers
2021     Ontario Health Repetitive Transcranial Magnetic Stimulation for People With Treatment-Resistant Depression
2021     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) Screening for common mental disorders during pregnancy and for traumatic experiences after delivery
2021     Ontario Health Pigmented lesion assay for suspected melanoma lesions
2021     Norwegian Institute of Public Health (NIPH) [Liposuction (lipectomy) for the treatment of fat accumulation caused by chronic lymphoedema]
2021     Ontario Health Proton Beam Therapy for Cancer in Children and Adults: A Health Technology Assessment
2021     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of the SpaceOAR hydrogel rectal spacer during prostate radiotherapy]
2021     Center for Evidence-based Practice (CEP) COVID-19: mandatory vaccination
2021     Ontario Health Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure
2021     Ontario Health Vaginal pessaries for pelvic organ prolapse and stress urinary incontinence
2021     Scottish Medicines Consortium (SMC) Secukinumab for the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence in adults who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs)
2021     Scottish Medicines Consortium (SMC) Brentuximab vedotin in combination with cyclophosphamide, doxorubicin and prednisone (CHP) is indicated for adult patients with previously untreated systemic anaplastic large cell lymphoma (sALCL)
2021     Scottish Medicines Consortium (SMC) Melatonin (Slenyto) for the treatment of insomnia in children and adolescents aged 2-18 with autism spectrum disorder (ASD) and / or Smith-Magenis syndrome, where sleep hygiene measures have been insufficient
2020     Technology Assessment at SickKids (TASK) Microcosting of whole genome sequencing (WGS) of trios in heterogeneous pediatric cardiac population
2020     Center for Evidence-based Practice (CEP) COVID-19: prophylactic use of hydroxychloroquine (HCQ)
2020     Center for Evidence-based Practice (CEP) COVID-19: treatment with hydroxychloroquine (HCQ)
2020     Center for Evidence-based Practice (CEP) COVID-19: infectivity of patients who have recovered from disease
2020     Center for Evidence-based Practice (CEP) Cytokine adsorption for treatment of COVID-19 disease
2020     Center for Evidence-based Practice (CEP) COVID-19: decontamination and reprocessing of personal protective equipment (PPE)
2020     Center for Evidence-based Practice (CEP) Transmission of respiratory infections via showers
2020     NIHR Health Technology Assessment programme Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial
2020     Center for Evidence-based Practice (CEP) Remdesivir for treatment of COVID-19 disease
2020     Center for Evidence-based Practice (CEP) COVID-19: sedation-ventilation liberation of COVID+ patients
2020     Center for Evidence-based Practice (CEP) COVID-19: surgical masks and filtering face piece respirators (FFR) for health care providers
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) Rapid collaborative review on the current role of antibody tests for novel coronavirus SARS-CoV-2 in the management of the pandemic
2020     Center for Evidence-based Practice (CEP) COVID-19: point-of-care (POC) testing
2020     NIHR Health Technology Assessment programme Best-practice prevention alone or with conventional or biological caries management for 3- to 7-year-olds: the FiCTION three-arm RCT
2020     Center for Evidence-based Practice (CEP) COVID-19: antibiotic management in ambulatory patients
2020     NIHR Health Technology Assessment programme Total versus partial knee replacement in patients with medial compartment knee osteoarthritis: the TOPKAT RCT
2020     Center for Evidence-based Practice (CEP) COVID-19: temperature screening for healthcare personnel
2020     Andalusian Health Technology Assessment Area (AETSA) [C-Reactive Protein point-of-care testing (CRP-POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections]
2020     Center for Evidence-based Practice (CEP) COVID-19: criteria for discharging patients from inpatient care
2020     Norwegian Institute of Public Health (NIPH) Safety, clinical effectiveness, predictive accuracy and cost effectiveness of blood based tests for women with suspected preeclampsia: a health technology assessment
2020     Center for Evidence-based Practice (CEP) COVID-19: high flow nasal cannula (HFNC)/non-invasive positive pressure ventilation (NIPPV) indications
2020     Center for Evidence-based Practice (CEP) COVID-19: proning considerations for patients on HFNC or BIPAP
2020     Center for Evidence-based Practice (CEP) COVID-19: criteria for advising home care patients to return to the hospital
2020     NIHR Health Services and Delivery Research programme Stroke Sentinel Audit Programme: Investigating and Evaluating Stroke Therapy (SSNAPIEST)
2020     Norwegian Institute of Public Health (NIPH) Intracoronary lithotripsy for the treatment of coronary artery disease: a health technology assessment
2020     Center for Evidence-based Practice (CEP) COVID-19: surge triage for suspected influenza-like illness
2020     NIHR Health Services and Delivery Research programme An evaluation of a multifaceted intervention to reduce antimicrobial prescribing in care home residents [REducing Antimicrobials in Care Homes (REACH)]: a non-randomised feasibility study and process evaluation
2020     Norwegian Institute of Public Health (NIPH) Disease modifying drugs for treatment of primary progressive multiple sclerosis: A health technology assessment
2020     NIHR Health Services and Delivery Research programme UK Study of tendon Achilles Rehabilitation multicentre randomised clinical trial (UK STAR)
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: pharmacological treatment of sexually transmitted and blood-borne infections ─ infections caused by chlamydia trachomatis and neisseria gonorrhoeae]
2020     NIHR Health Technology Assessment programme Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation
2020     NIHR Health Services and Delivery Research programme IMPlementation of A Relatives Toolkit (IMPART study): examining the critical success factors, barriers and facilitators to implementation of an online supported self-management intervention in the NHS
2020     NIHR Health Technology Assessment programme Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation
2020     Austrian Institute for Health Technology Assessment (AIHTA) Update PET/PET-CT evidence for need based planning in the area of oncology
2020     NIHR Health Technology Assessment programme Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation
2020     NIHR Health Technology Assessment programme Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation
2020     Austrian Institute for Health Technology Assessment (AIHTA) Proton and carbon ion therapy - an update on indications
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Endovascular treatment of varicose veins by radiofrequency ablation or cyanoacrylate closure]
2020     NIHR Health Technology Assessment programme Oral splints for patients with temporomandibular disorders or bruxism: a systematic review and economic evaluation
2020     NIHR Health Technology Assessment programme Interventions to reduce the risk of surgically transmitted Creutzfeldt–Jakob disease: a cost-effective modelling review
2020     Malaysian Health Technology Assessment (MaHTAS) Pre-dialysis education programme (PDEP)
2020     Malaysian Health Technology Assessment (MaHTAS) Diagnostic approaches to solitary pulmonary nodule (SPN)